Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy

Am Heart J. 1995 Nov;130(5):1089-93. doi: 10.1016/0002-8703(95)90213-9.


To examine the contribution of the angiotensin-converting enzyme (ACE) gene to hypertrophic cardiomyopathy (HCM), we determined the ACE insertion/deletion (I/D) polymorphism in 80 patients with HCM and 88 of their unaffected siblings and children. Patients were divided into familial or solitary HCM (FHCM or SHCM) groups with or without affected family members. Genotypes were identified by the polymerase chain reaction (PCR) with oligonucleotide primers flanking the polymorphic region in intron 16 of the ACE gene to amplify template DNA prepared from peripheral leukocytes. D-allele frequencies were 0.38 in all subjects, 0.42 in patients with HCM, and 0.35 in relatives (p < 0.05). The probability ratios were 1.98, 1.46, and 2.97 in patients with HCM, FHCM, and SHCM, respectively. The D allele frequency was higher in SHCM than in FHCM (p < 0.05). The findings suggest that HCM, especially in solitary cases, is partially determined by genetic disposition. Findings imply that the ACE D allele is one of the genetic contributing factors associated with cardiac hypertrophy in HCM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Base Sequence
  • Cardiomyopathy, Hypertrophic / ethnology
  • Cardiomyopathy, Hypertrophic / genetics*
  • Female
  • Genes, ras
  • Genotype
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic*


  • Peptidyl-Dipeptidase A